×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
LON:GDR

genedrive Share Forecast, Price & News

GBX 18.27
-1.23 (-6.31%)
(As of 06/27/2022 12:41 PM ET)
Add
Compare
Today's Range
18.23
20
50-Day Range
17.85
30
52-Week Range
10
82
Volume
320,296 shs
Average Volume
3.04 million shs
Market Capitalization
£16.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive GDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for genedrive and its competitors with MarketBeat's FREE daily newsletter.

GDR Stock Forecast (MarketRank)

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
genedrive logo

About genedrive (LON:GDR)

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

GDR Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
46
Year Founded
N/A

Company Calendar

Last Earnings
2/04/2020
Today
6/27/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£334 thousand
Cash Flow
GBX 6.60 per share
Book Value
GBX 8.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£16.91 million
Optionable
Not Optionable
Beta
N/A














genedrive Frequently Asked Questions

How has genedrive's stock performed in 2022?

genedrive's stock was trading at GBX 43 at the beginning of the year. Since then, GDR stock has decreased by 57.5% and is now trading at GBX 18.27.
View the best growth stocks for 2022 here
.

How were genedrive's earnings last quarter?

genedrive plc (LON:GDR) posted its quarterly earnings data on Tuesday, February, 4th. The company reported ($8.90) EPS for the quarter.
View genedrive's earnings history
.

Who are genedrive's key executives?

genedrive's management team includes the following people:
  • Mr. David Budd, CEO & Exec. Director (Age 54, Pay $242.19k)
  • Mr. Russell John Shaw, Chief Financial Officer & Director (Age 44)

What other stocks do shareholders of genedrive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other genedrive investors own include NVIDIA (NVDA), Altria Group (MO), Netflix (NFLX), SolGold (SOLG), Tiziana Life Sciences (TILS), Asbury Automotive Group (ABG), Allena Pharmaceuticals (ALNA), Amphenol (APH), Benchmark Electronics (BHE) and Bank of New York Mellon (BK).

What is genedrive's stock symbol?

genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."

How do I buy shares of genedrive?

Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is genedrive's stock price today?

One share of GDR stock can currently be purchased for approximately GBX 18.27.

How much money does genedrive make?

genedrive (LON:GDR) has a market capitalization of £16.91 million and generates £334 thousand in revenue each year.

How many employees does genedrive have?

genedrive employs 46 workers across the globe.

How can I contact genedrive?

genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The official website for genedrive is www.genedriveplc.com. The company can be reached via phone at +44-161-9890245.

This page (LON:GDR) was last updated on 6/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.